Around 1 in 5 breast cancer survivors who have undergone five years of therapy experience cancer recurrence within the following 10 years. But [s]Medical News Today[/s] reports that now researchers from the [b]Johns Hopkins Kimmel Cancer Centre[/b] in Baltimore have created a blood test that they say can detect breast cancer recurrence with up to 95% accuracy and help monitor a patient’s response to treatment. The research team developed a test called the cMethDNA assay, which can monitor 10 breast cancer-specific genes in patients’ blood. The findings are published in the journal [s]Cancer Research[/s].
[link url=http://www.medicalnewstoday.com/articles/275535.php]Full Medical News Today report[/link]
[link url=http://cancerres.aacrjournals.org/content/74/8/2160.abstract?sid=a9ffdc84-35ba-45fb-93e4-3bdde2b23ff4]CR abstract[/link]